News Release

• 08.20.2025 Seikagaku Announces an Application for Marketing Approval of SI-449, an Adhesion Barrier, as a Medical Device in Japan pdf (137KB)

  読む Seikagaku Announces an Application for Marketing Approval of SI-449, an Adhesion Barrier, as a Medical Device in Japan

• 08.07.2025 Notice of Conclusion of a Definitive Agreement Regarding Co-development and Marketing Collaboration in Japan on Gel-One pdf (3,944KB)

  読む Notice of Conclusion of a Definitive Agreement Regarding Co-development and Marketing Collaboration in Japan on Gel-One

• 08.05.2025 [Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025) pdf (413KB)

  読む [Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025)

• 07.11.2025 Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation pdf (122KB)

  読む Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation

More

What's New

• 08.05.2025 Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2026

  読む Seikagaku announced the financial results for the First Quarter of the Fiscal Year ending March 31, 2026

• 07.23.2025 Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2026 at 16:00 on August 5, 2025

  読む Seikagaku will announce the financial results for the First Quarter of the Fiscal Year ending March 31, 2026 at 16:00 on August 5, 2025

• 06.20.2025 New Message from President & CEO

  読む New Message from President & CEO

• 05.15.2025 Presentation Material for the Briefing on FY2024 Financial Results

  読む Presentation Material for the Briefing on FY2024 Financial Results

More

Who we are

More

What is Glycoscience

More

Our R&D

More